The impact of the COVID-19 pandemic on non-COVID induced sepsis survival
Yayımlandı: | BMC Anesthesiology 22(2022)S. 12 |
---|---|
Asıl Yazarlar: | Unterberg, Matthias (Yazar), Rahmel, Tim (Yazar), Köhler, Thomas (Yazar), Henzler, Dietrich (Yazar), Schwier, Elke (Yazar) |
Materyal Türü: | Makale |
Dil: | English |
Baskı/Yayın Bilgisi: |
2022
|
Konular: | |
Online Erişim: | https://doi.org/10.1186/s12871-021-01547-8 |
İlgili Kayıtlar: | In:
BMC Anesthesiology |
Benzer Materyaller
-
Dosing of Antimycotic Treatment in Sepsis-Induced Liver Dysfunction by Functional Liver Testing with LiMAx
Yazar:: Kirchner, Carmen, ve diğerleri
Baskı/Yayın Bilgisi: (2019) -
Does adjunctive hemoadsorption with CytoSorb affect survival of COVID-19 patients on ECMO? A critical statement
Yazar:: Köhler, Thomas, ve diğerleri
Baskı/Yayın Bilgisi: (2021) -
Interrupted Chain of Transmission in a Pediatric COVID-19 Case
Yazar:: Grautoff, Steffen
Baskı/Yayın Bilgisi: (2020) -
Hemoadsorption with CytoSorb and the early course of linezolid plasma concentration during septic shock
Yazar:: Köhler, Thomas, ve diğerleri
Baskı/Yayın Bilgisi: (2022) -
Profound decrease of liver maximum function capacity test of isoflurane sedated patients : a report of three cases
Yazar:: Schwier, Elke, ve diğerleri
Baskı/Yayın Bilgisi: (2021)